HAO

Haoxi Health Technology Ltd HAO

NasdaqSmall CapCommunication Services

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 3 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$54.83M

Quarter to Jun 30

Net income

$-9.54M

Quarter to Jun 30

Operating margin

-17.6%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$62.3K total
Marex Group plc
$39.2KNew
Virtu Financial LLC
$12.0KNew
XTX Topco Ltd
$11.1K-44.0%
See all 3 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2026
EDGAR

Net Income

FY 2026
EDGAR

EPS (Diluted)

FY 2026
EDGAR

Operating Margin

FY 2026
EDGAR

ROIC

FY 2026
EDGAR

Debt/Equity

FY 2026
EDGAR

Loading ratio trend…

HAO key financials by period

Reported revenue, net income and operating margin by fiscal year, from Haoxi Health Technology Ltd's annual filings on SEC EDGAR.

Haoxi Health Technology Ltd reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2026$54.8M$-9.5M-17.6%
FY 2025$32.8M$3.9M-6.1%
FY 2024$48.5M$1.3M3.5%
FY 2023$28.2M$969.8K4.2%
FY 2022$16.2M$244.6K1.7%
Source: HAO filings on SEC EDGAR →

HAO insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Haoxi Health Technology Ltd (HAO): stock profile, AI score and financials

Haoxi Health Technology Ltd (HAO) stock profile, AI quality score, and SEC EDGAR financial data, a Communication Services sector company. HAO is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 3 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2026), Haoxi Health Technology Ltd reports quarterly revenue of $54.8M, net income of $-9.5M, an operating margin of -17.6%. Top institutional holders of HAO by reported 13-F value include Marex Group plc, Virtu Financial, XTX Topco Ltd, based on the most recent SEC filings. HAO trades on the Nasdaq exchange and files with the SEC under CIK 1954594. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HAO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Haoxi Health Technology Ltd directly from SEC EDGAR.

SEC EDGAR: CIK 1954594 →